Innovative horizons: Perfusion-driven process intensification for HEK293 cells in cell and gene therapy

Authors

• Vera Ortseifen, Sartorius Xell GmbH, GermanyFollow
• Pia Brinkert, Sartorius Xell GmbH, Germany
• Niklas Kraemer, Sartorius Xell GmbH, Germany
• Tim Steffens, Sartorius Xell GmbH, Germany
• Sandra Klausing, Sartorius Xell GmbH, Germany
• Dennis Karthaus, Sartorius Xell GmbH, Germany
• Anica Schmidt, Sartorius Xell GmbH, Germany
• Kathrin Teschner, Sartorius Xell GmbH, Germany
• Vera Ortseifen, Sartorius Xell GmbH, Germany

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Vera Ortseifen, Pia Brinkert, Niklas Kraemer, Tim Steffens, Sandra Klausing, Dennis Karthaus, Anica Schmidt, Kathrin Teschner, and Vera Ortseifen, "Innovative horizons: Perfusion-driven process intensification for HEK293 cells in cell and gene therapy" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/201